The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Nanoparticle‐mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia‐reperfusion injury
Abstract
Excessive production of reactive oxygen species (ROS) after cerebral ischemia and reperfusion is implicated in brain damage through different cellular and molecular mechanisms, and it is further aggravated by impaired cellular antioxidant defense systems under ischemic conditions. Therapeutic strategies based on exogenous delivery of the native form of superoxide dismutase (SOD), a free radical scavenger, are limited because of its short half‐life (~6 min) in vivo and poor permeability across theblood‐brain‐barrier (BBB). We encapsulated SOD in biodegradable poly(D,L‐lactideco‐glycolide) nanoparticles (SOD‐NPs) and tested their efficacy in a rat focal cerebral ischemia‐reperfusion injury model. We hypothesized that localized brain delivery of SOD‐NPs would sustain the protective effect of SOD by neutralizing the deleterious effects of ROS formed following ischemia‐reperfusion. SOD‐NPs were administered at the time of reperfusion via the intracarotid route to maximize their localization in the brain. Animals receiving SOD‐NPs (10,000 U of SOD/ kg) demonstrated a 65% reduction in infarct volume, whereas an equivalent dose of SOD in solution (SOD– Sol) increased it by 25% over saline control (P<0.001; data at 6 h following reperfusion). Control NPs alone or mixed with SOD‐Sol were ineffective in reducing infract volume, with results similar to saline control, indicating the protective effect of the encapsulated enzyme. SOD‐NPs maintained BBB integrity, thereby preventing edema, reduced the level of ROS formed following reperfusion, and protected neurons from undergoing apoptosis. Animals treated with SOD‐NPs demonstrated greater survival than those with saline control (75% vs. 0% at 28 days) and later regained most vital neurological functions. SOD‐NPs may be an effective treatment option in conjunction with a thrombolytic agent for stroke patients.— Reddy, M. K., Labhasetwar, V. Nanoparticle‐mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia‐reperfusion injury. FASEB J. 23, 1384–1395 (2009)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Transduced Tat-SOD Fusion Protein Protects Against Ischemic Brain Injury
Kim, D. W., Eum, W. S., Jang, S. H., Kim, S. Y., Choi, H. S., Choi, S. H., An, J. J., Lee, S. H., Lee, K. S., Han, K., et al. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13141-4 · Cited by 62
RetractedReversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Cuzzocrea, S., Riley, D. P., Caputi, A. P., & Salvemini, D. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01484-4 · Cited by 1,087
A peptide carrier for the delivery of biologically active proteins into mammalian cells
Morris, M. C., Depollier, J., Mery, J., Heitz, F., & Divita, G. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1173 · Cited by 1,018
Pathophysiology, Clinical Manifestations, and Prevention of Ischemia-Reperfusion Injury
Collard, C. D., & Gelman, S. (2001) · Anesthesiology · doi:10.1097/00000542-200106000-00030 · Cited by 661
Oxidants, antioxidants and the ischemic brain
Warner, D. S., Sheng, H., & Batinić-Haberle, I. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.01022 · Cited by 598
Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles
Prabha, S., Zhou, W.-Z., Panyam, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00315-0 · Cited by 553
Self-citationZambaux, M. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00106-5 · Cited by 537
Characterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
Self-citation
Cited by
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Nance, E. A., Woodworth, G. F., Sailor, K. A., Shih, T.-Y., Xu, Q., Swaminathan, G., Xiang, D., Eberhart, C., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003594 · Cited by 649
Tiwari, S. K., Agarwal, S., Seth, B., Yadav, A., Nair, S., Bhatnagar, P., Karmakar, M., Kumari, M., Chauhan, L. K. S., Patel, D. K., et al. (2014) · ACS Nano · doi:10.1021/nn405077y · Cited by 558
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
Nanotechnological advances for the delivery of cns therapeutics.
Wong, H. L., Wu, X. Y., & Bendayan, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.007 · Cited by 488
Metadata
- Authors
- Reddy, M. K., & Labhasetwar, V.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-01-05
- Volume
- 23
- Issue
- 5
- Pages
- 1384-1395
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2158416613
- Cited by
- 264
- References
- 41
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nanoparticle‐mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia‐reperfusion injury. https://app.cochat.ai/papers/10.1096/fj.08-116947
- The paper
- Reddy, M. K., & Labhasetwar, V. (2009). Nanoparticle‐mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia‐reperfusion injury. The FASEB Journal. https://doi.org/10.1096/fj.08-116947
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.